Regenerative Medicine Market Industry Share, Trends, Growth, Future Prospects, Forecast 2021 | Future Market Insights Report with Expert Review

Over 17.9 million people die of cardiovascular diseases (CVDs) and 9.6 million of cancer each year, says the World Health Organization (WHO). With the mortality rate increasing every year, the global regenerative medicine market revenue is likely to grow to $39,012.0 million by 2030 from $8,186.9 million in 2019, at a 16.3% CAGR between 2020 and 2030.

This is because regenerative medicine is focused on repairing and recreating the tissues and cells destroyed by such diseases. In this regard, the regenerative medicine market is being driven by the rising geriatric population, as the elderly are more prone to chronic diseases than younger people. From 703 million in 2019, the number of people aged 65 and above around the world is set to reach 1.5 billion in 2050, as per the United Nations (UN).

Key Findings of Global Regenerative Medicine Market

• Demand for regenerative medicine rising for COVID treatment
• Mounting chronic disease burden strongest market growth driver
• Regenerative medicine majorly used to treat musculoskeletal diseases
• Emerging economies offering market players vast growth opportunities
• Highest adoption of regenerative medicine witnessed in North America
• Market fragmented due to existence of numerous key companies

Get the Sample Copy of this Report at @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1326

The COVID-19 pandemic initially hurt the regenerative medicine market growth prospects, as most of the non-essential hospital departments were shut down and much of the staff was redirected to COVID care. However, the race to find a novel treatment for the infection has led to a massive increase in the demand for regenerative medicine, especially cell-based therapies, across the globe.

In the past, the regenerative medicine market was dominated by the cell therapy category, based on type. Due to the havoc being wreaked by the COVID-19 pandemic, the number of clinical trials involving cell therapies as a potential treatment has risen manifold in the past few months.

The musculoskeletal category, under the application segment of the regenerative medicine market, is predicted to witness the fastest growth in the coming years. With the rising geriatric population, the prevalence of orthopedic diseases is increasing. Since such diseases often result in the wastage of the muscle and bone, regenerative medicine is proving essential for patients to live a normal life, by helping restore the bone and muscle density.

Browse detailed report with COVID-19 impact analysis on Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Musculoskeletal, Wound Care, Oncology, Dental, Ocular) – Global Industry Analysis and Demand Forecast to 2030 

In the years to come, the highest CAGR in the regenerative medicine market will be seen in the Asia-Pacific (APAC) region. Economic growth, surging private and public funding in medical research, rising incidence of chronic diseases, increasing population of the elderly, and growing medical tourism industry are driving the market in regional countries.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1326

The most-significant companies in the global regenerative medicine market are 3M Company, Smith & Nephew plc, Integra LifeSciences Holdings Corporation, Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet Holdings Inc., Amgen Inc., Novartis AG, Allergan plc, Organogenesis Holdings Inc., MiMedx Group Inc., Misonix Inc., Vericel Corporation, Takeda Pharmaceutical Company Limited, and Medtronic plc.

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

Essential Thrombocythemia Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.

Hypersensitivity Pneumonitis Market  Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.

Pyomyositis Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com